Aligos Therapeutics, Inc. (ALGS) NASDAQ

10.07

-0.17(-1.66%)

Updated at October 03 04:00PM

Currency In USD

Valuation

Market Cap249.58M
Enterprise Value220.96M
P/E Ratio-1.41
PEG Ratio0.06
Price/Sales Ratio19.52
Price/Book Ratio1.02
Enterprise/Revenue15.77
Enterprise/EBITDA-0.68

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-23.37
Operating Margin-24.73

Management Effectiveness

Return On Assets-0.55
Return On Equity-1.24

Income Statement

Revenue3.95M
Revenue/Share0.31
Gross Profit3.95M
EBITDA-89.15M
Net Income-131.21M
Diluted EPS-20.94

Balance Sheet

Total Cash123.06M
Total Cash/Share11.89
Total Debt6.88M
Total Debt/Equity0.07
Current Ratio6.31
Book Value Per Share9.84

Price History

52-Week Change23.41
52-Week High46.8
52-Week Low3.76
Moving Average 50 Days9.43
Moving Average 200 Days13.62

Statistics

Average Volume74,256
Shares Outstanding6.15M
% Held by Institutions26.14

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateAugust 19, 2024